HONZ(SZ:300086) Zheng Xing Xing Ye Ri Bao·2025-11-11 08:39Market Overview - The chemical pharmaceutical sector experienced a decline of 0.2% on November 11, with Kangzhi Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 4002.76, down 0.39%, while the Shenzhen Component Index closed at 13289.0, down 1.03% [1] Stock Performance - Notable gainers in the chemical pharmaceutical sector included: - Qianyan Bio (688221) with a closing price of 16.68, up 10.32% on a trading volume of 316,800 shares and a turnover of 514 million yuan [1] - Lianhuan Pharmaceutical (600513) closed at 24.00, up 7.48% with a trading volume of 443,800 shares [1] - Hongyuan Pharmaceutical (301246) closed at 21.98, up 7.22% with a trading volume of 459,600 shares [1] - Conversely, Kangzhi Pharmaceutical (300086) saw a decline of 3.77%, closing at 8.68 with a trading volume of 681,100 shares and a turnover of 592 million yuan [2] Capital Flow - The chemical pharmaceutical sector experienced a net outflow of 571 million yuan from institutional investors, while retail investors saw a net inflow of 368 million yuan [2] - Notable capital flows included: - Anglikang (002940) with a net inflow of 12.9 million yuan from institutional investors [3] - Hongyuan Pharmaceutical (301246) with a net inflow of 89.78 million yuan from institutional investors [3] - Lianhuan Pharmaceutical (600513) had a net inflow of 48.74 million yuan from institutional investors [3]